VideoHIVInternational Workshop on HIV Pediatrics 2021Bone Mineral Density/Content of Postpartum Mothers Taking Treatment Including DTG Vs EFV, TDF Vs TAF in Pregnancy and Their Infants: Randomized IMPAACT 2010 Trial - Tapiwa Mbengeranwa, ZimbabweView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Hypertensive Disorders in Pregnancy and HIV: A Province-Wide Cohort Analysis During 2018 and 2019 in the Western Cape, South Africa - Amy Slogrove, South AfricaView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Virological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of- Care in the ODYSSEY Trial - Cissy Kityo, UgandaView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Longitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa - Claire Davies, South AfricaView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Dolutegravir and Weight Gain to Adolescents Living with HIV at Baylor Mwanza-Tanzania - Esther Masunga, TanzaniaView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Weight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial - Hilda Angela Mujuru, ZimbabweView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021LATE BREAKER - Dolutegravir-Based Art is Superior to Standard of Care in Young Children Living With HIV - Pauline Amuge, UgandaView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa - Isaac Ravi Brenner, United StatesView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Pharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE Study - Tim Cressey, ThailandView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Long-Term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen In Children and Adolescents Living With HIV - Suvaporn Anugulruengkitt, ThailandView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 Kg: Preliminary Results from IMPAACT 2019 - Kristina Brooks, United StatesView Video
VideoHIVInternational Workshop on HIV Pediatrics 2021B/F/Taf in Virologically Suppressed Adolescents and Children: Two- Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers - Eva Natukunda, UgandaView Video
